Projects per year
Fingerprint
Dive into the research topics where Medical Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
-
-
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)
Sherman, M. E. (PI), Radisky, D. C. (CoPI) & Ruddy, K. J. (CoPI)
2/1/22 → 1/31/25
Project: Research project
-
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
all the NETTER-2 Trial Investigators, Jun 29 2024, In: The Lancet. 403, 10446, p. 2807-2817 11 p.Research output: Contribution to journal › Article › peer-review
-
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
Goetz, M. P., Toi, M., Huober, J., Sohn, J., Trédan, O., Park, I. H., Campone, M., Chen, S. C., Manso, L. M., Paluch-Shimon, S., Freedman, O. C., O'Shaughnessy, J., Pivot, X., Tolaney, S. M., Hurvitz, S. A., Llombart-Cussac, A., André, V., Saha, A., van Hal, G. & Shahir, A. & 2 others, , Aug 2024, In: Annals of Oncology. 35, 8, p. 718-727 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms
Rivera-Concepcion, J., Lo, Y. C., Uprety, D., Adjei, A. A., Ernani, V. & Leventakos, K., Mar 2024, In: Current Problems in Cancer: Case Reports. 13, 100284.Research output: Contribution to journal › Article › peer-review
Open Access